Technology
Health
Pharmaceutical

ObsEva

$9.68
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.52 (-5.10%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ObsEva and other stocks, options, ETFs, and crypto commission-free!

About OBSV

ObsEva SA engages in the development of therapeutic treatments for woman's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. Read More The company was founded by Ernest Loumaye and André Chollet in November 2012 and is headquartered in Geneva, Switzerland.

Employees
Headquarters
Geneva, Geneve (Geneva)
Founded
2012
Market Cap
443.13M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
67.46K
High Today
$10.35
Low Today
$9.27
Open Price
$10.27
Volume
49.66K
52 Week High
$19.40
52 Week Low
$9.27

Collections

Technology
Health
Pharmaceutical
Biopharmaceutical
2017 IPO
Europe (Non-UK)
Europe

OBSV News

Seeking AlphaJun 19

ObsEva advances Phase 3 trial for nolasiban following FDA meeting

485

OBSV Earnings

-$0.59
-$0.53
-$0.48
-$0.42
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 7, Pre-Market

Popular Stocks

More OBSV News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.